微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Streptomyces hygroscopicus subsp. hygroscopicus (Jensen) Waksman and Henrici |
|---|---|
| 商品货号： | TS135778 |
| Strain Designations： | FD 28576 N 787-182 |
| Application： | Produces C-13 beta-acyloxymilbemycins Produces N787-182 complex |
| Isolation： | Soil, Kurashiki City, Okayama Pref., Japan |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 172: N-Z amine with soluble starch and glucose |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Pfizer, Inc. |
| U.S. Patent Number： | |
| References： | Haxell MA, et al. C-13 beta-acyloxymilbemycins, a new family of macrolides. Discovery, structural determination and biological properties. J. Antibiot. 45: 659-670, 1992. PubMed: 1624368 Haxell MA, et al. Biologically pure culture of Streptomyces hygroscopicus TS135778 capable of producing antibiotic compounds. US Patent 5,573,946 dated Nov 12 1996 Haxell MA, et al. Process for producing antiparasitic macrolide antibiotics. US Patent 5,589,366 dated Dec 31 1996 |